GE HealthCare Q3 2026 net income jumps 38% to $615 million
GEHC•GE HealthCare said third-quarter 2026 net income attributable to the company rose 38% year over year to $615 million. Revenue increased 7% to $5.51 billion, and diluted EPS rose 39% to $1.36.
1. Quarterly results
GE HealthCare reported third-quarter 2026 revenue of $5.51 billion, up 7% year over year, and diluted EPS of $1.36, up 39%. Cash flow from operating activities climbed 53% to $907 million, including a $55 million tariff refund.
2. SOFIE acquisition
The planned $945 million cash acquisition of SOFIE Biosciences is expected to close in the first half of 2027, pending approvals.
